TrianglePUBLICATIONS · 28885700
Historical time to disease progression and progression-free survival in patients with recurrent/refractory neuroblastoma treated in the modern era on Children's Oncology Group early-phase trials.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Cancer
- Publication date
- 2017 Dec 15
- First author
- London WB
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- London WB
- type
- Author
- name
- Bagatell R
- type
- Author
- name
- Weigel BJ
- type
- Author
- name
- Fox E
- type
- Author
- name
- Guo D
- type
- Author
- name
- Van Ryn C
- type
- Author
- name
- Naranjo A
- type
- Author
- name
- Park JR
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- London WB
- type
- Author
- name
- Bagatell R
- type
- Author
- name
- Weigel BJ
- type
- Author
- name
- Fox E
- type
- Author
- name
- Guo D
- type
- Author
- name
- Van Ryn C
- type
- Author
- name
- Naranjo A
- type
- Author
- name
- Park JR
- type
- Author
- bibliography ids
- nci-bib-44391b28efc67f418aae7a0e
- book metadata
- content sha256
- 396acca6047fbae865af5b3e1e74e1b7f852231b7d5c055c0ddaaabb84ee9b1c
- document type
- citation
- dois
- 10.1002/cncr.30934
- electronic publication date
- display
- 2017 Sep 8
- precision
- day
- year
- 2017
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:28885700
- immutable id
- pubmed:28885700@396acca6047fbae865af5b3e1e74e1b7f852231b7d5c055c0ddaaabb84ee9b1c
- journal
- abbreviation
- Cancer
- issn electronic
- 1097-0142
- issn print
- 0008-543X
- issue
- 24
- name
- Cancer
- nlm unique id
- 0374236
- pages
- 4914-4923
- volume
- 123
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 28885700
- provenance
- batch id
- fb25b16edcb1373b70c1
- provider
- NCBI PubMed ESummary
- record sha256
- f2eacd1dc5e5c6a619671cdccd38b6136b28d13027ef430668d7560fc7418670
- response sha256
- 182c99bf1974b58308315b66aa28d31c61e8fc31cf3de4cadb0340a4f6734c52
- retrieved at
- 2026-09-09T23:47:28.490065+00:00
- publication date
- display
- 2017 Dec 15
- precision
- day
- year
- 2017
- publication types
- Journal Article
- Meta-Analysis
- Review
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Historical time to disease progression and progression-free survival in patients with recurrent/refractory neuroblastoma treated in the modern era on Children's Oncology Group early-phase trials.
Preserved source evidence · Not medical advice